- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06065423
Evaluation of Home Program and Telerehabilitation for the Treatment Process in Patients With Breast Cancer-Related Lymphedema
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation
-
İstanbul, Turkey, 34899
- Canan Şanal-Toprak
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients who had undergone breast surgery at least 3 months ago
- Had stage 1-2 lymphedema
- Had upper extremity lymphedema associated with breast cancer
Exclusion Criteria:
- Signs of infection such as lymphangitis, cellulitis, fungal infections
- Those with documented lymph node metastases
- Those with bilateral lymphedema
- Those with other diseases affecting upper extremity functions
- Those with a history of previous surgery related to the upper extremity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telerehabilitation Group
patients received exercises and massages through TR three times a week, conducted by a physiotherapist and a clinician.
They were encouraged to perform their exercises and wear compression garments on the remaining days.
Prior to the program, patients or their relatives received training from physiotherapists regarding exercises and Manual Lymphatic Drainage (MLD).
Patients or their relatives were informed about the Zoom program and were instructed to acquire the application online.
Two physiotherapists and groups of five patients each were organized based on rehabilitation days and hours, and access to the Zoom link was provided.
|
MLD:It is a unique massage technique that uses specific hand movements to provide a gentle pumping effect on the skin. Massage movements follow the direction of lymph flow and produce rapid results. The aim of this method is to achieve maximum skin tightening effect with minimum pressure. Exercise, on the other hand, increases physical performance, improves body composition, and provides an increase in quality of life by providing acute and chronic reductions in fatigue. Both aerobic exercises and strengthening exercises have been found effective on physical performance. It shows that a mixed program consisting of components such as aerobics, strengthening, coordination and stretching can positively affect flexibility, pain and energy expenditure in breast cancer patients. |
|
Active Comparator: Home- Exercise Group
patients were provided with a brochure explaining the massages and exercises they needed to perform.
Additionally, they were contacted three times a week by a physiotherapist and a clinician to remind them of the treatments, assess the continuity and accuracy of the treatments, encourage them to perform the treatments correctly and consistently, and promote the wearing of compression garments.
|
MLD:It is a unique massage technique that uses specific hand movements to provide a gentle pumping effect on the skin. Massage movements follow the direction of lymph flow and produce rapid results. The aim of this method is to achieve maximum skin tightening effect with minimum pressure. Exercise, on the other hand, increases physical performance, improves body composition, and provides an increase in quality of life by providing acute and chronic reductions in fatigue. Both aerobic exercises and strengthening exercises have been found effective on physical performance. It shows that a mixed program consisting of components such as aerobics, strengthening, coordination and stretching can positively affect flexibility, pain and energy expenditure in breast cancer patients. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Volume Measurements
Time Frame: Time Frame: Day 0
|
Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3
|
Time Frame: Day 0
|
|
Volume Measurements
Time Frame: Time Frame: 5 weeks
|
Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3
|
Time Frame: 5 weeks
|
|
Volume Measurements
Time Frame: Time Frame: 8 weeks
|
Arm measurement was measured with a tape measure at 4 cm intervals and calculated using the cone method in cm3
|
Time Frame: 8 weeks
|
|
Symptom Severity
Time Frame: Time Frame: Day 0
|
Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)
|
Time Frame: Day 0
|
|
Symptom Severity
Time Frame: Time Frame: 5 weeks
|
Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)
|
Time Frame: 5 weeks
|
|
Symptom Severity
Time Frame: Time Frame: 8 weeks
|
Shoulder pain, tightness, sensation of heaviness, and stiffness were evaluated using a numerical scale (1 to 10 points)
|
Time Frame: 8 weeks
|
|
Functionality
Time Frame: Time Frame: Day 0
|
Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire
|
Time Frame: Day 0
|
|
Functionality
Time Frame: Time Frame: 5 weeks
|
Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire
|
Time Frame: 5 weeks
|
|
Functionality
Time Frame: Time Frame: 8 weeks
|
Ouick Disabilities of the Arm, Shoulder and Hand (Quick DASH) questionnaire
|
Time Frame: 8 weeks
|
|
Efficacity
Time Frame: Time Frame: Day 0
|
Lymphedema Quality of Life Impact Scale
|
Time Frame: Day 0
|
|
Efficacity
Time Frame: Time Frame: 5 weeks
|
Lymphedema Quality of Life Impact Scale
|
Time Frame: 5 weeks
|
|
Efficacity
Time Frame: Time Frame: 8 weeks
|
Lymphedema Quality of Life Impact Scale
|
Time Frame: 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction with the treatment
Time Frame: Time Frame: 5 weeks
|
Responses were gathered on a scale of very satisfied - satisfied - somewhat satisfied - unsatisfied
|
Time Frame: 5 weeks
|
|
Patient satisfaction with the treatment
Time Frame: Time Frame: 8 weeks
|
Responses were gathered on a scale of very satisfied - satisfied - somewhat satisfied - unsatisfied
|
Time Frame: 8 weeks
|
|
patients were asked to compare their hand functionality to before the injury
Time Frame: Time Frame: 5 weeks
|
Responses were gathered on a scale of 'much better - somewhat better - same - somewhat worse - much worse
|
Time Frame: 5 weeks
|
|
patients were asked to compare their hand functionality to before the injury
Time Frame: Time Frame: 8 weeks
|
Responses were gathered on a scale of 'much better - somewhat better - same - somewhat worse - much worse
|
Time Frame: 8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: CANAN ŞANAL TOPRAK, Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09.2021.131
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.